1. Home
  2. DOLE vs WVE Comparison

DOLE vs WVE Comparison

Compare DOLE & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dole plc

DOLE

Dole plc

HOLD

Current Price

$12.97

Market Cap

1.3B

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.05

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOLE
WVE
Founded
1851
2012
Country
Ireland
Singapore
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
DOLE
WVE
Price
$12.97
$6.05
Analyst Decision
Hold
Strong Buy
Analyst Count
1
16
Target Price
$15.00
$29.81
AVG Volume (30 Days)
846.1K
2.3M
Earning Date
05-11-2026
04-28-2026
Dividend Yield
2.29%
N/A
EPS Growth
N/A
N/A
EPS
0.60
N/A
Revenue
$9,172,907,000.00
$3,704,000.00
Revenue This Year
$4.93
N/A
Revenue Next Year
$1.72
$85.67
P/E Ratio
$41.91
N/A
Revenue Growth
8.23
149.43
52 Week Low
$12.52
$5.02
52 Week High
$16.51
$21.73

Technical Indicators

Market Signals
Indicator
DOLE
WVE
Relative Strength Index (RSI) 31.61 54.18
Support Level $12.52 $6.02
Resistance Level $14.56 $6.30
Average True Range (ATR) 0.30 0.26
MACD -0.10 0.05
Stochastic Oscillator 14.29 67.62

Price Performance

Historical Comparison
DOLE
WVE

About DOLE Dole plc

Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace. Geographically, the company operates in United States, Ireland, U.K. Spain, Sweden, and Others.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: